Panacea Life Sciences Holdings Inc (PLSH)

[hempspeculator]

Revenues, profits, and cash flow. Not posters on message boards will determine the pps as per Peter Lynch.
https://www.fool.com/investing/2019/04/07/10-investing-tips-from-peter-lynch-that-you-should.aspx
So lets look at these numbers. Current revenue run rate is 1M for 2019. Currently this gives us a 28x revenue valuation or 2x the industry average and thus the pps imo is CURRENTLY overvalued. However, for 2020 the revenue is projected to be 70M to 100M or have increase 70x and at 10x "fair value" would be $15 to $20. For 2021 with a projected 800-1000 acres the revenues would thus grow (assuming current CBD prices)4x or to $280M plus. Again at 10x revenues we get a 2.8B market cap. Simply put with proper execution in a market expected to grow from 500M in 2019 to 22B in 2022, EXDI is expected to grow revenues 280x or 28000%. If you can name a similar opportunity please post it for the benefit of the board. Of course this will require execution, industry estimates to be realized and FDA cooperation and other legal and government regulatory issues to be amicably resolved. The current EXDI was born in Jan 2019 with a new float, new management, new investors, a new business plan, and new product based on the experience of Ceed2Med. Posters who confuse both pps and failures prior to Jan 2019 don't understand the opportunity and will fail to participate imo.